HOME >> BIOLOGY >> NEWS
Factor identified that makes treating aging hearts with gene therapy difficult

Scientists at Massachusetts General Hospital (MGH) and their colleagues have found why older cardiac cells are more difficult to treat with gene therapy than younger cells. The findings, published in the May 4, 2003, issue of Circulation, have implications for therapeutic strategies aimed at the aging population.

"Efforts to develop gene therapy for heart disease have been geared towards the elderly since they have fewer therapeutic options," says principal investigator Roger Hajjar, MD, of the Cardiovascular Research Center at MGH. "Our results show that we have some hurdles to overcome in order to optimize treatments in this population."

The researchers found that gene transfer by adenovirus is less efficient in aging rat heart cells than in cells from their younger counterparts. Over the years, adenoviruses have been used in laboratory and clinical research to deliver beneficial genes into their target cells. These modified viruses rely on several proteins on the surface of cells in order to gain entry and deliver therapeutic genes.

Hajjar's group had previously shown that aging cells are more resistant to entry by adenovirus than adult cells, but it had not been clear why. Through detailed laboratory experiments, the research team found that crucial proteins called integrins, which sit just under a cell's membrane, are scarce in older cardiac cells. It turns out that adenoviruses need these integrins to get into cells.

"The adenovirus binds to a receptor on the outside of a cell that is linked to integrins below the cell's surface," says Hajjar, who is an associate professor of Medicine at Harvard Medical School. "The receptor itself is abundant in older cells, but the integrins are deficient."

This may sound like bad news for the elderly, but Hajjar points out that it is possible to boost the expression of integrins. "The next step is to devise different ways of stimulating integrins specifically so you can still u
'"/>

Contact: Sue McGreevey
smcgreevey@partners.org
617-724-2764
Massachusetts General Hospital
3-Mar-2003


Page: 1 2

Related biology news :

1. Hemophilia therapy update: New information on investigational Factor VIII therapy development
2. Factor for acquiring skin barrier function identified
3. Enzyme Presence Could Be Key Factor In Wolf Health, Study Suggests
4. UCSF Scientists Report On A Transcription Factor That Could Stimulate Heart Cells To Repair Damage Caused By Heart Attacks Or Birth Defects
5. Genetic, Familial Factors Influence ADHD, Not Necessarily Sex Of Child
6. Allelix Clones Receptor For Intestinal Growth Factor GLP-2
7. Gene Influences Heart Disease And Stroke Risk Factors
8. Growth Factors Improve Muscle Healing In Animals
9. Growth Factor Contributes To Angiogenesis
10. One Way Traffic: Max Planck Scientists Idendified Genes Involved In Transporting An Important Plant Growth Factor
11. Environmental Factors Contribute To High Blood Pressure In African-American Males

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/25/2019)... ... September 25, 2019 , ... LeadingBiotech ... and dialogue, today announces its inaugural South CEO conference to be ... , Co-produced by Tulane University, this invitation-only meeting convenes biopharma executives to ...
(Date:9/24/2019)... ... September 24, 2019 , ... ... interactions for accelerated drug development, announced today that it has raised $2.8M from ... OS Fund and also includes AME Cloud Ventures, Boom Capital, Madrona Venture Group, ...
(Date:9/17/2019)... ... September 17, 2019 , ... Last week, Blackrock Microsystems, ... from the Medical University of Warsaw, met at the Presidential Palace of the ... a neuroprosthetic system as part of an initiative called "Startups in the Palace ...
Breaking Biology News(10 mins):
(Date:10/10/2019)... ... October 10, 2019 , ... R3 Stem Cell announces it has ... October 18-19th, 2019 in Las Vegas with spots still open. , The speaker, Dr. ... several Ivy League universities including Cornell, Harvard and Dartmouth. He currently serves as the ...
(Date:10/8/2019)... ... October 08, 2019 , ... Today, Massachusetts stem cell biotechnology company Asymmetrex ... Like the company’s precursor patent, approved in the U.S. in 2017, the new patent ... Asymmetrex now markets the technology in the U.S. as the AlphaSTEM Test™. ...
(Date:10/3/2019)... Calif. (PRWEB) , ... October 02, 2019 , ... ... business opportunity to investors and venture capital companies in Silicon Valley at a special ... 8:30 pm. The event will be held at the JJ Lake Business Center located ...
(Date:9/30/2019)... ... September 30, 2019 , ... The September ... Rigaku Corporation , is now available online on the company’s global website. The ... including X-ray diffraction, fluorescence and imaging, and presents articles, scientific papers and news ...
Breaking Biology Technology:
Cached News: